Page last updated: 2024-08-21

indazoles and Mixed Tumor, Mullerian

indazoles has been researched along with Mixed Tumor, Mullerian in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brady, WE; Campos, SM; DiSilvestro, PA; Hanjani, P; Hensley, ML; Lee, PS; Moxley, KM; O'Cearbhaill, RE; O'Malley, DM; Rose, PG; Rotmensch, J; Thaker, PH; Zuna, RE	1

Trials

1 trial(s) available for indazoles and Mixed Tumor, Mullerian

Article	Year
A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: a gynecologic oncology group study. Gynecologic oncology, 2014, Volume: 133, Issue:3 Topics: Aged; Angiogenesis Inhibitors; Carcinosarcoma; Disease-Free Survival; Female; Humans; Indazoles; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Recurrence, Local; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Sulfonamides; Treatment Outcome; Uterine Neoplasms	2014

Article

Year

A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: a gynecologic oncology group study.

Gynecologic oncology, 2014, Volume: 133, Issue:3

Topics: Aged; Angiogenesis Inhibitors; Carcinosarcoma; Disease-Free Survival; Female; Humans; Indazoles; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Recurrence, Local; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Sulfonamides; Treatment Outcome; Uterine Neoplasms

2014